Board of Directors Biographies
Lanhee J. Chen, JD, PhD
Dr. Chen is chair of the Board of Directors of El Camino Hospital. He is the David and Diane Steffy Research Fellow at the Hoover Institution; director of Domestic Policy Studies and lecturer in the Public Policy Program at Stanford University; lecturer in Law at Stanford Law School; and an affiliate of the Freeman Spogli Institute for International Studies at Stanford University.
He is a presidentially-appointed and Senate-confirmed member of the Social Security Advisory Board, a bipartisan and independent body that advises the president, Congress, and other policymakers on matters relating to the Social Security program. During the George W. Bush administration he served as a senior appointee at the U.S. Department of Health and Human Services.
He earned his PhD and AM in political science from Harvard University, his JD cum laude from Harvard Law School, and his AB magna cum laude in government from Harvard College. The El Camino Healthcare District Board appointed Dr. Chen to the El Camino Hospital Board for a second three-year renewable term, which expires on June 30, 2021.
Jeffrey M. Davis, MD, MPH
Jeffrey M. Davis, MD, MPH, is a senior health consultant with the global health and benefits consultancy of Willis Towers Watson. Prior to his role at WTW he served as senior medical director for xG Health Solutions, a Geisinger Health System company with expertise in accountable care/population health/analytics. He arrived at xG after seven years as the Chief Medical Officer of Avivia Health/Kaiser Permanente.
The District Board appointed Dr. Davis to the El Camino Hospital Board in 2012 for a one-year term, then re-appointed him twice to three-year terms, the last expiring in June 2019. He currently serves as a member of the Hospital Board and serves on the Quality, Patient Care and Patient Experience Committee, and as chair of the Investment Committee.
Dr. Davis earned his medical degree from the Columbia College of Physicians and Surgeons in New York. He completed both a pediatric residency and clinical research fellowship training in medical genetics at the University of California, San Francisco Medical Center. He is board certified in both pediatrics and medical genetics, Dr. Davis also received his BA from Princeton University/undergraduate fellow at the Woodrow Wilson School of International and Public Affairs and a master’s degree in epidemiology from the University of California, Berkeley School of Public Health.
Peter C. Fung, MD, MS, FACP, FAAN, FAHA
Peter C. Fung*, MD, MS, FACP, FAAN, FAHA, is a neurologist at El Camino Health. Dr. Fung is a member of the Chinese Health Initiative, El Camino Health Chinese-speaking Physician Referral Network, committed to treating, educating and working with the Chinese community.
In addition, he serves on the Stroke Council of the American Heart Association (AHA). He specializes and is board certified in stroke and vascular neurology, pain medicine and clinical neurophysiology (EEG, EMG). He has special interests in the treatment of migraines, seizure disorders, Alzheimer's disease, Parkinson's disease, stroke medicine and cerebrovascular disease.
In November 2014, the public elected Dr. Fung to his first four-year term on the District Board of Directors. He was re-elected to the El Camino Healthcare District board for his second four-year term on November 6, 2018. He’s the District Board Chair and serves on the El Camino Hospital Board. He is serving his second term on the Hospital Board. He is chair of the Governance Committee and a member of the Quality Committee. Dr. Fung also previously served as the Board liaison to the Community Benefit Advisory Council. Because of his Board responsibilities, Dr. Fung stepped down as medical director of El Camino Hospital Stroke Program, which has been highly rated with multiple awards and recognitions.
Dr. Fung earned his medical degree from the University of Hong Kong and a master’s degree in neurophysiology from the University of Michigan. He completed his residencies in Michigan — internal medicine at Oakwood Hospital and Medical Center in Dearborn and neurology at the University of Michigan, Ann Arbor.
Gary Kalbach was elected by the El Camino Healthcare District Board to the El Camino Hospital Board on January 16, 2018, for a renewable term, which expires June 30, 2021. He currently serves as a member of the Hospital Board and on the Finance, Governance and Investment Committees. He also serves as the Board liaison to the El Camino Health Foundation Board.
Mr. Kalbach has more than 30 years of experience in finance/entrepreneurship, strategic planning and partnership formation. He has served on the board of more than 50 technology-based companies as a venture capital investor. He has also served on the Board’s Governance Committee since 2012 and the Investment Committee since 2015.
Prior to this, Mr. Kalbach was the founding president and chair of the Board of the Fogarty Institute of Innovation at El Camino Health. Previously, he was chair of the Board of Directors of Children’s Hospital (now Lucile Packard Children’s Hospital). Additionally, since his retirement from a venture capital firm in 2006, he has served on numerous not-for-profit organizations. Mr. Kalbach earned his Master of Business Administration from San Jose State University and a Bachelor of Science from University of California, Berkeley.
Julie Kliger, MPA, BSN, RN
Julie Kliger, MPA, BSN, RN, was elected by the El Camino Healthcare District Board to the El Camino Hospital Board on January 16, 2018, for a renewable term, which expires June 30, 2020. She currently serves as a member of the Hospital Board and on the Executive Compensation and Quality, Patient Care and Patient Experience Committees.
Ms. Kliger is a managing director at the management consulting firm Alvarez & Marsal and is a key member of their West Coast Health Care Practice. She has more than 25 years of experience in leading large-impact care model redesign, strategic conversions, business development, and organizational change management implementation.
Ms. Kliger started her career in healthcare as a nurse at Stanford Children’s Hospital and Highland Hospital in Oakland, California. She earned her Master of Public Administration from Harvard University, Bachelor of Science in Nursing from Columbia University, and Bachelor of Arts from University of California, Berkeley. Ms. Kliger is a Fellow of the California Health Care Foundation and has authored several peer-reviewed papers.
Julia E. Miller
Julia E. Miller* founded her consulting firm, Miller Enterprises, after serving eight years as mayor and council member for the City of Sunnyvale. She has extensive government experience having served on the boards of many agencies, including the Association of Bay Area Governments, Bay Area Economic Forum, Bay Area Air Quality Management District, Sustainable Silicon Valley, San Francisco Bay Trail, San Francisco FBI Community Academy Alumni Association, Leadership Sunnyvale and the Sunnyvale Historical Society.
A long-time Lockheed Martin employee before entering politics, Ms. Miller was publicly elected to her first term on the El Camino Healthcare District Board in November 2012 and elected to the El Camino Hospital Board in December 2012. She began her second four-year term in December 2016.
She currently serves on the Compliance and Audit Committee. She previously served on the Executive Compensation Committee; the Quality, Patient Care and Patient Experience Committee; and as chair of the Governance Committee. She is currently the Hospital Board secretary/treasurer and the District Board Vice Chair.
She is the past vice chair of the Association of California Healthcare Districts (ACHD) Board of Directors, and currently represents the District Board on the Silicon Valley Tobacco Securitization Joint Powers Authority in the role of vice president. As well, Ms. Miller is a member of the Board of Directors of the Silicon Valley Tobacco Securitization Corporation and the Santa Clara County Airport Commission.
Bob Rebitzer began his first term on the El Camino Hospital Board July 1, 2017, and currently serves on the Board's Governance Committee and Compliance and Audit Committee. Mr. Rebitzer is a managing director at Manatt Health, the consulting division of Manatt Phelps.
Prior to his current role, Mr. Rebitzer was chief operating officer of Stanford University's Clinical Excellence Research Center, advisor to the CEO at the California Healthcare Foundation and a senior vice president at United Behavioral Health, the mental health subsidiary of United Health Group. He was also a partner at Accenture where he was a founding member of the healthcare strategy practice.
George O. Ting, MD
George O. Ting, MD*, was elected to the El Camino Healthcare District Board of Directors on November 6, 2018, and joined the El Camino Hospital Board of Directors on December 7, 2018.
John L. Zoglin
John Zoglin* is the IBM Cloud Business Unit Worldwide Digital paid media leader. He was first appointed to the District Board in 2007, reappointed in 2008, and publicly elected to his second full term in 2012. He began his third four-year term in December 2016.
Mr. Zoglin currently serves on the Hospital Board Executive Compensation Committee and as the chair of the Finance Committee. He also serves as the Board liaison to the Community Benefit Advisory Council. He follows his father in service to El Camino Hospital; Dr. Stanton Zoglin served as the hospital’s chief of staff in the early 1960s. Mr. Zoglin earned a bachelor’s degree in economics from Harvard University and a master’s degree in business administration from Stanford Graduate School of Business.
*Also serve on El Camino Healthcare District Board.